Research Projects & Grants

For Profit Organization

• A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022., Role: Investigator, Mylan Pharmaceuticals, (11/2023 - 03/2024) Status: Completed
• A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis. Protocol: ARGX-113-2308, Role: Investigator, Argenx BV, (12/2024 - 12/2025) Status: Approved